Clinical Trial Detail

NCT ID NCT01141478
Title Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Loma Linda University
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.